Akebia Therapeutics (AKBA) has been on a downward spiral lately with significant selling pressure. After declining 39.9% over the past four weeks, the stock looks well positioned for a trend reversal ...

Hedge fund managers like David Einhorn, Bill Ackman, or Carl Icahn became billionaires through reaping large profits for their investors, which is why piggybacking their stock picks may provide us ...

Akebia Therapeutics Inc. (Nasdaq: AKBA) is giving investors optimism due to recent surges and heavy trading activity. In fact, AKBA stock is one of the hottest penny stocks available at the moment.

At the moment, there are a multitude of signals investors put to use to assess stocks. Some of the less utilized signals are hedge fund and insider trading activity. Our experts have shown that, ...

Akebia Therapeutics Inc. (NASDAQ:AKBA) is one of the best growth stocks to buy for the next 20 years. On February 6, Piper Sandler analyst Allison Bratzel lowered the firm’s price target on Akebia to ...

Akebia Therapeutics, Inc.AKBA is a biopharmaceutical company that could be an interesting play for investors. That is because, not only does the stock have decent short-term momentum, but it is seeing ...

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Is Akebia Therapeutics (AKBA) one of those stocks right now? A quick glance at the ...

Akebia Therapeutics Inc. Annual cash flow by MarketWatch. View AKBA net cash flow, operating cash flow, operating expenses and cash dividends.

Akebia Therapeutics Inc. Annual stock financials by MarketWatch. View the latest AKBA financial statements, income statements and financial ratios.